iBreast Exam
84% Sensitivity. 94% Specificity. 98% NPV.
Science behind iBreastExam
Ingredients: Coffee + Base of Support + Dash of Luck = Innovation
Invented at Drexel University, Philadelphia.
iBreastExam’s sensors accurately assess & identify tissue elasticity differences between hard & stiff breast tumors versus normal breast tissue. The patented tactile sensor technology using Piezoelectric Sensor Array was invented by the scientists and doctors at Drexel University. It is a novel, quantitative and low-cost elastic modulus (E) sensor that can measure tissue compression and stiffness by top down touching of the skin surface. iBE’s ability to apply a gentle force and measure the subtle displacements electrically, all within the sensor, makes for an ideal ‘electronic palpation’ sensor for in-vivo breast imaging.
How It Works
Early Detection is for Every Woman
Indian Journal of Gynecologic Oncology (2016)
A major clinical study with 916 women enrolled, evaluating iBE™ technology was published in the Indian Journal of Gynecologic Oncology in June 2016. The study showed that iBreastExam device can significantly enhance clinical breast examination Sensitivity (by 19%) while maintaining high Specificity (94%) and Negative Predictive Value (NPV) of 98%. The study concluded that iBreastExam can be a promising tool for early detection of clinically relevant lesions at early stages and also useful in younger women with dense breasts.